Thursday, September 22, 2011 8:28:43 PM
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=67313207
I probably should have paid more attention to Amphastar's court filings and considered the "conspiracy theory" possiblity that the FDA might be pressured into approving Amphastar's generic. The Akin Gump firm which represented Amphastar in its suit against the FDA is politically well-connected, having been co-founded by Robert Strauss, who chaired the DNC in the 70s, and having as current partners Vernon Jordan (Clinton Administration) and Tommy Thompson (former Republiican governor).
Fortunately MNTA's lawsuit is based on its process patents as has been pointed out, and it does not attack the FDA approval, which would likely be a losing proposition even if it could be shown that the FDA applied its standards with less rigor in approving Amphastar's generic. IMO, MNTA's suit has much greater upside than downside potential with a good chance of resolution in the not too distant future.
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
